BANK OF AMERICA CORP /DE/ - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 162 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$93,891
-57.5%
97,803
-66.8%
0.00%
Q1 2023$220,884
+288.6%
294,512
+90.7%
0.00%
Q4 2022$56,845
-83.5%
154,470
-80.7%
0.00%
Q3 2022$344,000
+429.2%
799,814
+857.2%
0.00%
Q2 2022$65,000
-29.3%
83,555
+16.1%
0.00%
Q1 2022$92,000
-98.9%
71,997
-99.0%
0.00%
-100.0%
Q4 2021$8,756,000
+2972.3%
6,894,656
+5166.7%
0.00%
Q3 2021$285,000
-80.4%
130,910
-66.3%
0.00%
Q2 2021$1,456,000
-26.7%
388,373
-36.3%
0.00%
Q1 2021$1,987,000
+66.4%
609,649
+74.1%
0.00%
Q4 2020$1,194,000
-48.8%
350,222
-38.7%
0.00%
Q3 2020$2,330,000
+167.2%
571,173
+121.5%
0.00%
Q2 2020$872,000
+63.9%
257,814
+13.0%
0.00%
Q1 2020$532,000
-40.4%
228,065
-6.9%
0.00%
Q4 2019$892,000
-65.9%
245,019
-22.2%
0.00%
Q3 2019$2,613,000
-13.1%
315,009
-9.8%
0.00%
Q2 2019$3,007,000
-59.1%
349,100
-49.3%
0.00%
-100.0%
Q1 2019$7,359,000
+353.1%
688,339
+270.8%
0.00%
Q4 2018$1,624,000
+7.9%
185,636
+107.2%
0.00%
Q3 2018$1,505,000
-58.7%
89,587
-48.5%
0.00%
-100.0%
Q2 2018$3,647,000
+32.9%
174,020
+2.0%
0.00%
Q1 2018$2,745,000
-68.2%
170,572
-62.6%
0.00%
-100.0%
Q4 2017$8,636,000
+81.2%
455,652
+34.6%
0.00%0.0%
Q3 2017$4,765,000
+177.0%
338,612
+46.6%
0.00%
Q2 2017$1,720,000
+14.1%
230,939
-0.3%
0.00%
Q1 2017$1,507,000
+123.6%
231,750
+52.3%
0.00%
Q4 2016$674,000
+74.6%
152,131
+84.1%
0.00%
Q3 2016$386,000
+57.6%
82,629
+122.2%
0.00%
Q2 2016$245,000
+49.4%
37,193
+43.9%
0.00%
Q1 2016$164,000
-23.7%
25,852
-27.7%
0.00%
Q4 2015$215,000
+38.7%
35,744
+38.2%
0.00%
Q3 2015$155,000
-82.1%
25,867
-79.5%
0.00%
Q2 2015$864,000
+5660.0%
126,339
+5175.1%
0.00%
Q1 2015$15,000
-89.3%
2,395
-88.2%
0.00%
Q4 2014$140,000
-32.0%
20,279
-19.5%
0.00%
Q3 2014$206,000
-0.5%
25,178
-0.4%
0.00%
Q2 2014$207,000
-16.2%
25,287
-19.7%
0.00%
Q1 2014$247,000
-41.9%
31,476
-34.4%
0.00%
Q4 2013$425,000
-39.1%
48,005
-42.4%
0.00%
Q3 2013$698,000
-5.4%
83,310
-15.7%
0.00%
Q2 2013$738,00098,7800.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders